Massive study tracks advanced prostate cancer treatment in real life

NCT ID NCT07344779

Not yet recruiting Disease control Sponsor: Bayer Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how well a drug called darolutamide works in real-world settings for men with advanced prostate cancer that has spread. It will follow about 1,600 men who are already receiving this drug as part of their standard care, either with or without chemotherapy. The main goal is to see how many men achieve very low levels of a cancer marker (PSA) after one year of treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE SENSITIVE PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Many Locations

    Multiple Locations, Belgium

  • Many Locations

    Multiple Locations, Finland

  • Many Locations

    Multiple Locations, France

  • Many Locations

    Multiple Locations, Germany

  • Many Locations

    Multiple Locations, Greece

  • Many Locations

    Multiple Locations, Israel

  • Many Locations

    Multiple Locations, Italy

  • Many Locations

    Multiple Locations, Lithuania

  • Many Locations

    Multiple Locations, Norway

  • Many Locations

    Multiple Locations, Poland

  • Many Locations

    Multiple Locations, Portugal

  • Many Locations

    Multiple Locations, Saudi Arabia

  • Many Locations

    Multiple Locations, Spain

  • Many Locations

    Multiple Locations, Sweden

  • Many Locations

    Multiple Locations, Switzerland

  • Many Locations

    Multiple Locations, United Kingdom

Conditions

Explore the condition pages connected to this study.